Terms: = Germ cell tumor AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Clinical Outcome
18 results:
1. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
[TBL] [Abstract] [Full Text] [Related]
2. Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer.
Urbaniak A; Reed MR; Heflin B; Gaydos J; Piña-Oviedo S; Jędrzejczyk M; Klejborowska G; Stępczyńska N; Chambers TC; Tackett AJ; Rodriguez A; Huczyński A; Eoff RL; MacNicol AM
Biomed Pharmacother; 2022 Sep; 153():113440. PubMed ID: 36076555
[TBL] [Abstract] [Full Text] [Related]
3. stat3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice.
Bitsch R; Kurzay A; Özbay Kurt F; De La Torre C; Lasser S; Lepper A; Siebenmorgen A; Müller V; Altevogt P; Utikal J; Umansky V
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35301236
[TBL] [Abstract] [Full Text] [Related]
4. Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients.
Del Bianco P; Pinton L; Magri S; Canè S; Masetto E; Basso D; Padovan M; Volpin F; d'Avella D; Lombardi G; Zagonel V; Bronte V; Della Puppa A; Mandruzzato S
Front Immunol; 2021; 12():809826. PubMed ID: 35069595
[TBL] [Abstract] [Full Text] [Related]
5. CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma.
Liu F; Huang J; He F; Ma X; Fan F; Meng M; Zhuo Y; Zhang L
Sci Rep; 2020 Jul; 10(1):10768. PubMed ID: 32612110
[TBL] [Abstract] [Full Text] [Related]
6. The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibition.
Craveiro RB; Ehrhardt M; Velz J; Olschewski M; Goetz B; Pietsch T; Dilloo D
Oncotarget; 2017 Jul; 8(29):46915-46927. PubMed ID: 28159923
[TBL] [Abstract] [Full Text] [Related]
7. CD133
Garg N; Bakhshinyan D; Venugopal C; Mahendram S; Rosa DA; Vijayakumar T; Manoranjan B; Hallett R; McFarlane N; Delaney KH; Kwiecien JM; Arpin CC; Lai PS; Gómez-Biagi RF; Ali AM; de Araujo ED; Ajani OA; Hassell JA; Gunning PT; Singh SK
Oncogene; 2017 Feb; 36(5):606-617. PubMed ID: 27775079
[TBL] [Abstract] [Full Text] [Related]
8. HDAC7 inhibition resets stat3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies.
Peixoto P; Blomme A; Costanza B; Ronca R; Rezzola S; Palacios AP; Schoysman L; Boutry S; Goffart N; Peulen O; Maris P; Di Valentin E; Hennequière V; Bianchi E; Henry A; Meunier P; Rogister B; Muller RN; Delvenne P; Bellahcène A; Castronovo V; Turtoi A
Oncogene; 2016 Aug; 35(34):4481-94. PubMed ID: 26853466
[TBL] [Abstract] [Full Text] [Related]
9. RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop.
Giladi ND; Ziv-Av A; Lee HK; Finniss S; Cazacu S; Xiang C; Waldman Ben-Asher H; deCarvalho A; Mikkelsen T; Poisson L; Brodie C
Oncotarget; 2015 Sep; 6(26):22680-97. PubMed ID: 26267319
[TBL] [Abstract] [Full Text] [Related]
10. Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells.
Khan FH; Pandian V; Ramraj S; Aravindan S; Herman TS; Aravindan N
BMC Genomics; 2015 Jul; 16(1):501. PubMed ID: 26148557
[TBL] [Abstract] [Full Text] [Related]
11. stat3 serine 727 phosphorylation influences clinical outcome in glioblastoma.
Lin GS; Chen YP; Lin ZX; Wang XF; Zheng ZQ; Chen L
Int J Clin Exp Pathol; 2014; 7(6):3141-9. PubMed ID: 25031733
[TBL] [Abstract] [Full Text] [Related]
12. stat3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma.
Lin GS; Yang LJ; Wang XF; Chen YP; Tang WL; Chen L; Lin ZX
Med Oncol; 2014 Apr; 31(4):924. PubMed ID: 24652192
[TBL] [Abstract] [Full Text] [Related]
13. Cryptotanshinone inhibits human glioma cell proliferation by suppressing stat3 signaling.
Lu L; Li C; Li D; Wang Y; Zhou C; Shao W; Peng J; You Y; Zhang X; Shen X
Mol Cell Biochem; 2013 Sep; 381(1-2):273-82. PubMed ID: 23740516
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of stat3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways.
Wang Y; Chen L; Bao Z; Li S; You G; Yan W; Shi Z; Liu Y; Yang P; Zhang W; Han L; Kang C; Jiang T
Oncol Rep; 2011 Nov; 26(5):1173-80. PubMed ID: 21887474
[TBL] [Abstract] [Full Text] [Related]
15. Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy.
Feng X; Zhang B; Wang J; Xu X; Lin N; Liu H
Med Oncol; 2011 Mar; 28(1):24-30. PubMed ID: 20221717
[TBL] [Abstract] [Full Text] [Related]
16. The transcriptional network for mesenchymal transformation of brain tumours.
Carro MS; Lim WK; Alvarez MJ; Bollo RJ; Zhao X; Snyder EY; Sulman EP; Anne SL; Doetsch F; Colman H; Lasorella A; Aldape K; Califano A; Iavarone A
Nature; 2010 Jan; 463(7279):318-25. PubMed ID: 20032975
[TBL] [Abstract] [Full Text] [Related]
17. Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b.
Wang W; Edington HD; Rao UN; Jukic DM; Land SR; Ferrone S; Kirkwood JM
Clin Cancer Res; 2007 Mar; 13(5):1523-31. PubMed ID: 17332298
[TBL] [Abstract] [Full Text] [Related]
18. Retinoic acid increases proliferation rate of GL-15 glioma cells, involving activation of STAT-3 transcription factor.
Paillaud E; Costa S; Fages C; Plassat JL; Rochette-Egly C; Monville C; Tardy M
J Neurosci Res; 2002 Mar; 67(5):670-9. PubMed ID: 11891779
[TBL] [Abstract] [Full Text] [Related]
